- Download: PDF | Citation | XML
- Print article
- Order Reprints
Published in the December 2004 Issue of PLoS Medicine
Share this Article info
Open Access
Correction
Correction: Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral-Therapy-Naive Patients Infected with HIV-1
- To add a note, highlight some text. Hide notes
- Make a general comment
Citation: (2004) Correction: Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral-Therapy-Naive Patients Infected with HIV-1. PLoS Med 1(3): e73. doi:10.1371/journal.pmed.0010073
Published: December 28, 2004
Copyright: © 2004 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Published October 19, 2004
In PLoS Medicine, volume 1, issue 1:
Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral-Therapy-Naive Patients Infected with HIV-1
Frank van Leth, Prahpan Phanuphak, Erik Stroes, Brian Gazzard, Pedro Cahn, et al.
DOI: 10.1371/journal.pmed.0010019
The following information was missing from the legend for Figure 1: closed squares, NVP; open squares, EFV; error bars denote standard errors. Oliver Flint at Bristol-Myers Squibb alerted PLoS Medicine to this omission.
Figure 1. Change in Plasma Concentrations of Lipids and Lipoproteins
Adjusted for sex, region, pVL decrease, and CD4+-cell increase. Closed squares, NVP; open squares, EFV; error bars denote standard errors.
doi:10.1371/journal.pmed.0010073.g001There was also a line with open circles in Figure 1F that should not have been included.
Add a note to this text.
Post Your Note (For Public Viewing)